Literature DB >> 7979521

Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis.

M B Viana1, M Murao, G Ramos, H M Oliveira, R I de Carvalho, M de Bastos, E A Colosimo, W S Silvestrini.   

Abstract

One hundred and twenty eight Brazilian children with lymphoblastic leukaemia were intensively treated with a Berlin-Frankfurt-Munich based protocol. More children had a white cell count above 50 x 10(9)/l (31%) then observed in developed countries. After a median follow up of 31 months (11-58 months), the estimated probability of relapse free survival was 41% (7%) for the whole group. After adjustment in the Cox's multivariate model, malnutrition was the most significant adverse factor affecting duration of complete remission. Age above 8 years and high peripheral white cell count were also significant adverse factors. Among the nutritional indices, the height for age and weight for age z scores were both significant, whether the cut off points of z-2 or z = -1.28 were chosen to define malnutrition. A strong statistical association between the two indices was found; the contribution of height for age z score to the prediction of relapse free survival was more significant. Children with height for age z score < -2 had a relapse risk of 8.2 (95% confidence interval 3.1 to 21.9) relative to children with z score > -2. The results of this study suggest that socioeconomic and nutritional factors should be considered in the prognostic evaluation of children with leukaemia in developing countries.

Entities:  

Mesh:

Year:  1994        PMID: 7979521      PMCID: PMC1030006          DOI: 10.1136/adc.71.4.304

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  26 in total

1.  Prognosis of black children with acute lymphocytic leukemia.

Authors:  T W Pendergrass; R Hoover; I I Godwin JD
Journal:  Med Pediatr Oncol       Date:  1975

2.  Update of St Jude Study XI for childhood acute lymphoblastic leukemia.

Authors:  G K Rivera; C H Pui; M L Hancock; H Mahmoud; V Santana; J T Sandlund; C Hurwitz; R Ribeiro; W Furman; W M Crist
Journal:  Leukemia       Date:  1992       Impact factor: 11.528

3.  An update of the results of intensive therapy in children with acute lymphoblastic leukemia.

Authors:  S Pavlovsky; F Sackmann Muriel; M T Santarelli; E Svarch; E Jiménez; R Kohan; A Rosso
Journal:  Leukemia       Date:  1992       Impact factor: 11.528

Review 4.  Acute lymphoblastic leukemia in children: an update of clinical, biological, and therapeutic aspects.

Authors:  D R Miller; L P Miller
Journal:  Crit Rev Oncol Hematol       Date:  1990       Impact factor: 6.312

5.  Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance?

Authors:  H A Davies; L Lennard; J S Lilleyman
Journal:  BMJ       Date:  1993-05-08

6.  Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).

Authors:  O B Eden; J S Lilleyman; S Richards; M P Shaw; J Peto
Journal:  Br J Haematol       Date:  1991-06       Impact factor: 6.998

7.  Social class as a prognostic variable in acute lymphoblastic leukaemia.

Authors:  W R McWhirter; H Smith; K M McWhirter
Journal:  Med J Aust       Date:  1983-10-01       Impact factor: 7.738

8.  Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols.

Authors:  C M Niemeyer; A Reiter; H Riehm; M Donnelly; R D Gelber; S E Sallan
Journal:  Ann Oncol       Date:  1991 Nov-Dec       Impact factor: 32.976

9.  The changing survivorship of white and black children with leukemia.

Authors:  M Szklo; L Gordis; J Tonascia; E Kaplan
Journal:  Cancer       Date:  1978-07       Impact factor: 6.860

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  18 in total

1.  Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group.

Authors:  Etan Orgel; Richard Sposto; Jemily Malvar; Nita L Seibel; Elena Ladas; Paul S Gaynon; David R Freyer
Journal:  J Clin Oncol       Date:  2014-03-31       Impact factor: 44.544

2.  Non-compliance with oral chemotherapy in childhood leukaemia.

Authors:  J S Lilleyman; L Lennard
Journal:  BMJ       Date:  1996-11-16

3.  Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia.

Authors:  Nobuko Hijiya; John C Panetta; Yinmei Zhou; Emily P Kyzer; Scott C Howard; Sima Jeha; Bassem I Razzouk; Raul C Ribeiro; Jeffrey E Rubnitz; Melissa M Hudson; John T Sandlund; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

4.  Malnutrition as a prognosis factor in lymphoblastic leukemia: a multivariate analysis.

Authors:  J J Reilly; I Odame; B E Gibson; B A Wharton
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

5.  Survival after acute lymphocytic leukaemia: effects of socioeconomic status and geographic region.

Authors:  J A Schillinger; P C Grosclaude; S Honjo; M J Quinn; A Sloggett; M P Coleman
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 6.  Important aspects of nutrition in children with cancer.

Authors:  Jacqueline Bauer; Heribert Jürgens; Michael C Frühwald
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

7.  Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group.

Authors:  Conrad V Fernandez; James Anderson; Norman E Breslow; Jeffrey S Dome; P E Grundy; Elizabeth J Perlman; Daniel M Green
Journal:  Pediatr Blood Cancer       Date:  2009-02       Impact factor: 3.167

8.  Nutritional assessment of children with hematological malignancies and their subsequent tolerance to chemotherapy.

Authors:  Vijay Gandhi Linga; A K Shreedhara; A T K Rau; Aarathi Rau
Journal:  Ochsner J       Date:  2012

9.  Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Authors:  Megan E Burke; Elizabeth R Lyden; Jane L Meza; Elena J Ladas; Roshni Dasgupta; Ellen A Wiegner; Carola A S Arndt
Journal:  Pediatr Blood Cancer       Date:  2013-01-17       Impact factor: 3.167

Review 10.  Non-surgical oncology - Guidelines on Parenteral Nutrition, Chapter 19.

Authors:  J Arends; G Zuercher; A Dossett; R Fietkau; M Hug; I Schmid; E Shang; A Zander
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.